Health Policy Project

The Health Policy Project has ended, but work continues under a new USAID five-year project, Health Policy Plus (HP+).

PUBLICATION

share this publication:
Share on Facebook   Share on Twitter
Use of Naltrexone in the Treatment of Opioid Dependence in the Russian Federation: Situation Analysis

Author(s): Nicole Judice

Primary Language: English

Date: 9/17/2012

Abstract:

Russia faces significant challenges in diagnosing and treating HIV given the dual epidemic of drug dependence and HIV. In support of the country's efforts, the Health Policy Project assessed the potential for and effectiveness of scaling up naltrexone use. Naltrexone is already approved to treat drug dependence and alcoholism and is on Russia’s essential drugs list. In exploring its use, it appears to be a viable option for pharmaceutical treatment of opiate dependence. Note that other pharmacotherapies are not approved for use in Russia. This situation analysis attempts to identify the perspectives, attitudes, and understanding of practitioners and civil society representatives on how naltrexone use could be used to address HIV and drug dependence in Russia.


Tags: Click to view other publications with selected tag.

HIV    People Living With HIV (PLHIV)    People who Inject Drugs (PWID)    Report    Russia  
 
   RSS Feed
About
Our Work
How We Help
Partners
Our Team
Contact
What We Do
FP/RH
HIV
Maternal Health
All Topics
Countries
AFR Region
AME Region
E&E Region
LAC Region
Resources
Publications
Software and Models
eLearning
News
Links
User Info
Privacy Policy
RSS
Site Map
Staff Intranet
USAID Logo
The Health Policy Project is a five-year cooperative agreement funded by the U.S. Agency for International Development under Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010. The project's HIV-related activities are supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). It is implemented by Futures Group, in collaboration with Plan International USA, Avenir Health (previously Futures Institute), Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and White Ribbon Alliance for Safe Motherhood (WRA). The information provided on this Web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.

Copyright © 2011 Futures Group. All Rights Reserved.